Moderna, Inc. Common Stock vs. Taysha Gene Therapies, Inc. Common Stock
MRNA
Moderna, Inc. Common Stock
$226.89 +4.07%
VS TSHATaysha Gene Therapies, Inc. Common Stock
$4.11 +4.31%
Moderna, Inc. Common Stock (MRNA) comes out ahead, leading on 2 of 2 compared factors.
Size & Scale
| MRNA | TSHA | |
|---|---|---|
| Market Cap | $87.04 billion | $1.28 billion |
MRNA leads on 1 of 1 size & scale factors.
Risk & Sentiment
| MRNA | TSHA | |
|---|---|---|
| Short Interest | 0.01% | 0.08% |
MRNA leads on 1 of 1 risk & sentiment factors.
Dig deeper: MRNA overview, MRNA financials, TSHA overview, TSHA financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.